Skip to content

Multicenter clinical study on optimization schemes of heat-sensitive moxibustion of acupoints for the treatment of asthma (chronic phase)

Optimization shemes evaluation and clinical common technology research--Study on optimization schemes of heat-sensitive moxibustion of acupoints for the treatment of asthma (chronic phase)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000599
Enrollment
Unknown
Registered
2009-11-27
Start date
2008-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma(chronic duration)

Interventions

A:heat-sensitive moxibustion (intervention group)
B:seretide (control group)

Sponsors

Affiliated Hospital of Jiangxi Institute of Traditional Chinese Medicines
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: All must meet the following six criteria: 1. Meet the diagnostic criteria of bronchial asthma in Western medcine; 2. Asthma is at a chronic duration stage and severity is at 2, 3 grade; 3. Heat-sensitivity appears within the two outer lateral lines of dorsal Bladder Meridian of Foot-Taiyang, the area between the two horizontal lines of feishu and geshu, 6 inch outer the first and second rib gap of anterior chest; 4. Aged 18 to 65 years old; 5. The patients have normal sensorium, can express the moxibustion sense correctly and cooperate; 6. Participate in this study voluntarily and sign informed consent book.

Exclusion criteria

Exclusion criteria: With one of the following items should not be included in this study; 1. The patients have the other diseases that also cause breathlessness or dyspnea,such as bronchiectasis, cor pulmonale, pulmonary fibrosis, tuberculosis, pulmonary abscess, chronic obstructive pulmonary disease and so on; 2. Pregnant or breast-feeding women; 3. Complicated with serious life-threatening diseases, such as heart and brain blood vessels, liver, kidney and hematopoietic system disease and psychotic patients; 4. Hormone dependence type patients, or the people who used systemic adrenal cortical hormone (intravenous, intramuscular injection, subcutaneous injection andoral administration)within 4 weeks before recruiting.

Design outcomes

Primary

MeasureTime frame
pulmonary function test;asthmatic symptom scores;asthma attack frequency;

Countries

China

Contacts

Public ContactRixin Chen
chenrixin123@yahoo.com.cn+86 13870995605

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 30, 2026